Morgan Stanley »

Peregrine Pharmaceuticals shares owned by Morgan Stanley

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-03-31 $9.3M 1.4M 6.70
2023-09-30 $9.8M 1.0M 9.50
2023-06-30 $15M 1.1M 13.97
2022-12-31 $16M 1.2M 13.78
2022-06-30 $16M 1.2M 13.70
2022-03-31 $25M 1.2M 20.37
2021-06-30 $15M 599k 25.65
2020-12-31 $4.8M 414k 11.55
2020-09-30 $66k 8.6k 7.58
2020-06-30 $236k 36k 6.55
2020-03-31 $57k 11k 5.12
2019-12-31 $799k 104k 7.67
2019-09-30 $119k 22k 5.31
2019-03-31 $56k 13k 4.24
2018-12-31 $339k 83k 4.10
2018-09-30 $591k 86k 6.87
2018-06-30 $473k 121k 3.92
2018-03-31 $34k 12k 2.89